Taylor Wessing Partner Mark Barron writes a guide for UK startups looking to launch in Europe, published by Startups Magazine.
Taylor Wessing

Taylor Wessing is a full-service international law firm, working with clients in the world’s most dynamic industries. We take a single-minded approach to advising our clients, helping them succeed by thinking innovatively about their business issues. We support clients wherever they want to do business. The firm has a sector focus with experts in technology, media and communications, life sciences and private
Our 28 offices around the world (including Cambridge) blend the best of local business, industry and cultural knowledge with international experience to provide astutely commercial solutions for our clients. Our work includes:
Venture Capital
Taylor Wessing acts for technology and life sciences companies throughout their life-cycle, from start-up to exit, as well as funds and large corporates investing in technology, both in the UK and internationally. For early stage companies, we have created TW Tech Focus with advice on the legal issues to be encountered and a suite of freely available funding and IP protection documents. The quality of Taylor Wessing's venture capital practice has been independently recognised in the 2020 Chambers & Partners publication with the firm being solely listed in Band 1 in the venture capital category.
Technology/ Intellectual Property
We have a group of lawyers advising technology and life sciences companies on all aspects of their commercial arrangements. Many members of the team have worked in-house, been seconded to technology-based or life science companies and/or worked outside the law, for example as computer programmers or research scientists in the laboratory.
We are used to advising clients on their IP strategy, helping them to evaluate whether and to what extent they should seek protection for their IP, including brand protection – we have our own trade mark filing practice. We are also one of the law firms in England most regularly instructed to act on patent disputes. Our patents group works to resolve disputes where possible, but our success rate at trial is unequalled by any other law firm in England.
A market leader in these areas, we deliver constructive, commercial advice through a partner-driven service with total commitment to our clients.
Other practice areas
In addition to the above, we provide a full range of legal services including finance, competition, employment, employee benefits, tax, real estate and dispute resolution, both in the UK and across the world. Taylor Wessing clients include leading financial institutions, major corporations, public sector bodies and wealthy individuals and families.
Additional resources
- Synapse is Taylor Wessing’s international thought leadership in life sciences. Synapse draws on the firm’s international expertise to provide you with insight and practical guidance likely to affect your organisation.
- Taylor Wessing's Global Data Hub draws on Taylor Wessing's international expertise to provide you with insight and guidance on data protection issues
There are no Products & Services to display
Taylor Wessing joins forces with UKHospitality ahead of court action to support the hospitality sector.
International law firm Taylor Wessing has advised on the sale of the Glide group to the infrastructure fund Alinda Capital Partners.
Taylor Wessing has advised the world's largest commerce content monetisation platform, Skimlinks, on its acquisition by leading customer acquisition platform Connexity.
International law firm Taylor Wessing has advised The Rohatyn Group on its investment in Optimapharm d.d. (Optimapharm), a contract research organisation headquartered in Croatia, with 14 offices across Europe, including a heavy presence in CEE. The investment establishes a partnership with the company’s founders Gordana Gregurić Čičak and Igor Čičak.
Life Sciences specialist Alison Dennis has joined the Taylor Wessing partnership. Alison will work alongside Michael Stein as International Co-Head of our Life Sciences and Healthcare team.
International law firm Taylor Wessing has advised sports publisher The Athletic on its acquisition of UK-based football media channel Tifo Football.
Taylor Wessing has advised Niantic, a leading augmented reality and mobile real-world company, in its acquisition of 3D spatial mapping leader 6D.ai.
Taylor Wessing advises Gousto, the UK’s largest online meal-kit manufacturer, on its latest £32 million fundraising round.
Taylor Wessing has advised the UK Government on the establishment of its new £500m 'Future Fund' to support start-up technology and life sciences companies.
Taylor Wessing has advised Glenmark, the Mumbai-headquartered pharmaceutical company, on the sale of its central nervous system (CNS) product portfolio business in Poland.
Taylor Wessing has advised Rockpool Investments LLP on its investment in MomentumABM Ltd (Momentum), an account-based marketing consultancy provider.
The global crisis caused by the COVID-19 pandemic is being closely monitored by all parties and no less the financial regulators.
Where did 2019 leave copyright in the UK and what is ahead for 2020?
Taylor Wessing has advised Cazoo, one of the UK’s leading new tech businesses, on its latest £100 million funding round.
Taylor Wessing is one of the lead advisers in respect of British Steel, one of the highest-profile corporate collapses in recent years.
Taylor Wessing has advised MindBridge Ai on its acquisition of Brevis Limited, an accountancy technology firm serving the UK.
Taylor Wessing has been named as the recipient of "The Impact Case of the Year" award at The Managing IP EMEA Awards 2020 for its work for global generic and specialty pharmaceuticals company, Mylan.
Taylor Wessing has advised Thought Machine, a UK-based fintech company, on its USD 83 million Series B funding.
Taylor Wessing has advised Digital Surgery, a privately-held pioneer in surgical AI, data and analytics and digital education and training, on its sale to Medtronic, the global leader in medical technology.
Pages
There are no events to display
There are no jobs to display
No Blog articles found